HomeAbout

TL;DR CNBC


Novavax's coronavirus vaccine generates promising immune response in early trial, data shows - TL;DR CNBC

Novavax's coronavirus vaccine generates promising immune response in early trial, data shows

Publishing timestamp: 2020-08-04 20:05:34


Summary


Sentiment: NEGATIVE

Tickers: NVAXPFEMRNA

Keywords:

Source: https://www.cnbc.com/2020/08/04/novavaxs-coronavirus-vaccine-shows-promise-in-early-stage-trial.html


Developed by Leo Phan